Company intelligence / Profile preview

Panag Pharma Inc.

Halifax, Nova Scotia, Canadapanagrx.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Developing plant-based remedies for pain management. Their product AWAYE™ is Health Canada approved with a Natural Product Number and was undergoing clinical trials as of 2019.

Therapeutic areas: NephrologyImmunologyDermatologyRheumatologyGastroenterologyOphthalmologyNeurologyInfectious Diseases
Modalities: Cannabinoid-based formulations
Industry: Biotech

Drug pipeline

1 asset

AOTC

Phase 2

Indications: Pain, Inflammation

Beyond the preview

Go deeper on Panag Pharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panag Pharma Inc..

Explore the full profile